HALO
Halozyme Therapeutics, Inc. · Healthcare
Director Jeffrey William Henderson sold $962K of Halozyme Therapeutics, Inc.
Sold$962,200
$48.11Price
20,000Shares
−34%Stake
What HALO did after the filing
- The stock from Thu, Mar 2 open, $47.27
- −24.6%
- S&P 500, same days
- +5.4%
Measured over 30 trading days, to the Apr 14 close.
Traded Tue, Feb 28. Filed Wed, Mar 1, 6:07 PM ET, after the close. Returns use the Mar 2 open and the Apr 14 close. Not investment advice.